HSDTWHelius Medical Technologies, Inc.

About Helius Medical Technologies, Inc. (HSDTW)

Helius Medical Technologies, Inc. (HSDTW) is a N/A company headquartered in Newtown, PA, United States whose shares trade over-the-counter on the Pink tier.

Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company’s first commercial product is the Portable Neuromodulation Stimulator. For more information about the PoNS® or Helius Medical Technologies, visit www.heliusmedical.com.

Products and services

The Portable Neuromodulation Stimulator (“PoNS”) is an innovative, non-implantable, orally applied therapy that delivers neurostimulation through a mouthpiece connected to a controller and it’s used, primarily at home, with physical rehabilitation exercise, to improve balance and gait. The PoNS device, which delivers mild electrical impulses to the tongue, is indicated for use in the United States as a short-term treatment of gait deficit due to mild-to-moderate symptoms from multiple sclerosis (“MS”) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. PoNS has shown effectiveness in treating gait or balance and a significant reduction in the risk of falling in stroke patients in Canada, where it received authorization for sale in three indications: (i) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke and is to be used in conjunction with physical therapy; (ii) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (“mmTBI”) and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy. For more information visit www.ponstherapy.com.

HSDTW key facts

Ticker symbol

HSDTW

Market tier

Pink

Headquarters

Newtown, PA, United States

Country of incorporation

US

Year of incorporation

2014

Employees

21

Estimated market cap

$14.898 (as of May 12, 2025)

Shares outstanding

7,449

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Helius Medical Technologies, Inc. leadership

• Dane Andreeff — CEO
• Jeffrey Mathiesen — CFO
• Antonella Favit-VanPelt — CMO
• Emily Johns — Legal Counsel

Explore more: Pink stocks · OTC stocks starting with H